Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 8 (August)

1. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
   Am J Surg Pathol, 31(8): 1175-80. [Abstract] [Full-text]
2. Vulvar melanoma: a multivariable analysis of 644 patients.
   Obstet Gynecol, 110(2): 296-301. [Abstract] [Full-text]
3. Decreased tumor surveillance after adoptive T-cell therapy.
   Cancer Res, 67(15): 7467-76. [Abstract] [Full-text]
4. esiRNA to eri-1 and adar-1 genes improving high doses of c-myc-directed esiRNA effect on mouse melanoma growth inhibition.
   Biochem Biophys Res Commun, 361(2): 373-8. [Abstract] [Full-text]
5. Functional expression of human-epidermal-growth-factor receptor in a melanoma cell line.
   Biotechnol Appl Biochem, 48: 21-7. [Abstract] [Full-text]
6. WP760, a melanoma selective drug.
   Cancer Chemother Pharmacol, 60(5): 625-33. [Abstract] [Full-text]
7. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis.
   Clin Cancer Res, 13(16): 4817-24. [Abstract] [Full-text]
8. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
   Cancer Res, 67(16): 7875-84. [Abstract] [Full-text]
9. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
   Cancer Res, 67(16): 7833-40. [Abstract] [Full-text]
10. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma.
    Cancer Res, 67(16): 7559-64. [Abstract] [Full-text]
11. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Clin Cancer Res, 13(16): 4934-42. [Abstract] [Full-text]
12. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
    J Invest Dermatol, 127(9): 2207-15. [Abstract] [Full-text]
13. Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein.
    J Invest Dermatol, 127(9): 2191-206. [Abstract] [Full-text]
14. Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model.
    J Invest Dermatol, 127(9): 2184-90. [Abstract] [Full-text]
15. Indications for excision of nevi and melanoma diagnosed in a pediatric surgical unit.
    J Pediatr Surg, 42(8): 1412-6. [Abstract] [Full-text]
16. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting.
    Biomaterials, 28(31): 4673-83. [Abstract] [Full-text]
17. Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis.
    Oncogene, 26(39): 5808-15. [Abstract] [Full-text]
18. Analysis of gene expression in the tumor-associated macrophage.
    J Surg Res, 142(1): 119-28. [Abstract] [Full-text]
19. Rosmarinic acid induces melanogenesis through protein kinase A activation signaling.
    Biochem Pharmacol, 74(7): 960-8. [Abstract] [Full-text]
20. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
    Int J Cancer, 121(8): 1764-70. [Abstract] [Full-text]
21. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
    Int J Cancer, 121(8): 1729-37. [Abstract] [Full-text]
22. Id1 expression is transcriptionally regulated in radial growth phase melanomas.
    Int J Cancer, 121(8): 1705-9. [Abstract] [Full-text]
23. Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
    Cancer Immunol Immunother, 56(11): 1853-60. [Abstract] [Full-text]
24. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells.
    Int J Cancer, 121(8): 1690-6. [Abstract] [Full-text]
25. Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.
    J Clin Oncol, 25(25): 3802-7. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.